GC Cell (KRX:144510), under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5 CAR‑NK cell therapy. This 'first ...
Dosing was initiated in a Phase 1 single and multiple ascending dose study of SCY-247, the Company's second-generation triterpenoid antifungal in development for the treatment of severe invasive ...
Investing News Network on MSN6h
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, ...
Completed enrollment of Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps; top-line data expected ...
A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...
Alzamend Neuro plans a Phase 2 trial of AL001 for PTSD in late 2025, aiming for better lithium delivery, improved safety, and ...
Anecdotal evidence has long suggested that sleep problems are especially common for people with Moebius syndrome. Now, a new ...
Treatment-emergent adverse events (TEAEs) occurred in a similar proportion of patients in each group, and were mostly mild or ...
The expansion aims to enhance access to clinical studies and reinforce the island’s position as a hub for biomedical research. #NewsismyBusiness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback